The evolving value assessment of cancer therapies: Results from a modified Delphi study.

ABSTRACT: The move toward early detection and treatment of cancer presents challenges for value assessment using traditional endpoints. Current cancer management rarely considers the full economic and societal benefits of therapies. Our study used a modified Delphi process to develop principles for defining and assessing value of cancer therapies that aligns with the current trajectory of oncology research and reflects broader notions of value. 24 experts participated in consensus-building activities across 5 months (16 took part in structured interactions, including a survey, plenary sessions, interviews, and off-line discussions, while 8 participated in interviews). Discussion focused on: 1) which oncology-relevant endpoints should be used for assessing treatments for early-stage cancer and access

SUBMITTER: Lee M 

PROVIDER: S-EPMC10924144 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature